首页/数据集/Demographic, cognitive, and medication adherence profiles of stroke survivors at five years post-stroke.

Demographic, cognitive, and medication adherence profiles of stroke survivors at five years post-stroke.

Figshare2019-10-17 更新2026-04-29 收录

数据链接：

https://figshare.com/articles/dataset/Demographic_cognitive_and_medication_adherence_profiles_of_stroke_survivors_at_five_years_post-stroke_/9997694 数据链接链接失效反馈

官方服务：

资源简介：

Demographic, cognitive, and medication adherence profiles of stroke survivors at five years post-stroke.

应用场景：

创建时间：

2019-10-17

前列腺癌治疗

用药依从性

Androgen deprivation therapy (ADT) is standard for advanced prostate cancer. Relugolix, a gonadotropin-releasing hormone (GnRH) receptor antagonist, is the only oral ADT, with limited real-world data

DataCite Commons2025-11-12 更新70

Predicting short-term interruptions of antiretroviral therapy from summary adherence data: Development and test of a probability model

治疗中断预测

用药依从性

Antiretroviral therapy (ART) for HIV is vulnerable to unplanned treatment interruptions–consecutively missed doses over a series of days–which can result in virologic rebound. Yet clinicians lack a si

NIAID Data Ecosystem60

Additional file 9 of Accuracy and concordance of measurement methods to assess non-adherence after renal transplantation - a prospective study

移植术后管理

用药依从性

Additional file 9. a: Course of unadjusted means of the self-assessed intervention effect. 9 b: Boxplots for the self-assessed intervention effect.

Figshare2020-03-31 更新50

DataSheet2_Comprehensibility of a personalized medication overview compared to usual-care prescription drug labels.docx

药物信息理解

用药依从性

Poor understanding of prescription drug label (PDL) instructions can lead to medication errors, suboptimal treatment (side) effects, and non-adherence. A personalized medication hard-copy overview lis

NIAID Data Ecosystem70

Association between experiencing side effects of artesunate/amodiaquine malaria chemoprevention (ASAQ-CP) in the first round of mass drug administration (MDA) with initiation of ASAQ-CP in the second round of the MDA, during the Ebola outbreak, Monrovia, Liberia, 2014 (Poisson regression).

疟疾化学预防效果评估

用药依从性

Association between experiencing side effects of artesunate/amodiaquine malaria chemoprevention (ASAQ-CP) in the first round of mass drug administration (MDA) with initiation of ASAQ-CP in the second

NIAID Data Ecosystem50

Demographic, cognitive, and medication adherence profiles of stroke survivors at five years post-stroke.

资源简介：

相关数据集